Glaxo SmithKline
- 40.22 EGP
- 0.98
- 2.50%
Glaxo SmithKline Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 40.22 |
| Prev. Close | 39.240 |
| Day Range | 39.50 - 42.00 |
| 52WK range | |
| Turnover (M EGP) | 3.11 |
| Volume (M) | 0.08 |
| Number of Trades | 209 |
| Market Cap (M EGP) | 3,358.94 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 40.40 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
GSK Egypt posts EGP 106m consolidated profits in 9M-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) registered an annual growth in consolidated net profit after tax to EGP 105.82 million...
GSK Egypt’s net profits hike in H1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) posted consolidated net profits amounting to EGP 92.55 million in the first half (H1)...
GSK Egypt turns to loss in Q1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024,...
GSK Egypt obtains shareholders’ nod for 2023 cash dividends
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) plans to disburse cash dividends valued at EGP 0.75 per share for 2023, according to a bourse...
GSK Egypt’s consolidated profits plunge to EGP 60m...
Cairo – Mubasher: GlaxoSmithKline’s (GSK Egypt) consolidated net profit plunged to EGP 60.47 million in 2023 from EGP 735.39 million a...
